Abstract
Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired hematopoietic stem cell disorder characterized by clonal blood cells that are deficient in glycosylphosphatidylinositol-anchored proteins because of somatic mutations of the PIG-A gene. Many patients with PNH have more than one PNH clone, but it is unclear whether a single PNH clone remains dominant or minor clones eventually become dominant. Furthermore, it is unknown how many hematopoietic stem cells (HSCs) sustain hematopoiesis and how long a single HSC can support hematopoiesis in humans. To understand dynamics of HSCs, we reanalyzed the PIG-A gene mutations in 9 patients 6 to 10 years after the previous analyses. The proportion of affected peripheral blood polymorphonuclear cells (PMNs) in each patient was highly variable; it increased in 2 (from 50% and 65% to 98% and 97%, respectively), was stable in 4 (changed less than 20%), and diminished in 3 (94%, 99%, and 98% to 33%, 57%, and 43%, respectively) patients. The complexity of these results reflects the high variability of the clinical course of PNH. In all patients, the previously predominant clone was still present and dominant. Therefore, one stem cell clone can sustain hematopoiesis for 6 to 10 years in patien...Continue Reading
References
Nov 1, 1992·International Immunology·E UedaT Kinoshita
Oct 3, 1991·The New England Journal of Medicine·R E WareW F Rosse
Nov 9, 1995·The New England Journal of Medicine·P HillmenJ V Dacie
Feb 26, 1993·Science·T MiyataT Kinoshita
Apr 16, 1994·Lancet·M BesslerL Luzzatto
Jan 27, 1994·The New England Journal of Medicine·T MiyataT Kinoshita
May 21, 1993·Cell·J TakedaT Kinoshita
Jan 1, 1995·Advances in Immunology·T KinoshitaJ Takeda
Jul 12, 1996·Science·M OsawaH Nakauchi
Aug 31, 1996·Lancet·G SociéE Gluckman
Jan 10, 1997·Cell·L LuzzattoB Rotoli
Mar 23, 1999·British Journal of Haematology·Y AzenishiT Kitani
Aug 16, 2000·The EMBO Journal·R WatanabeT Kinoshita
Nov 9, 2000·The Journal of Experimental Medicine·K SudoH Nakauchi
Nov 9, 2000·The Journal of Experimental Medicine·H EmaH Nakauchi
Jan 1, 1964·Proceedings of the National Academy of Sciences of the United States of America·J E TILLL SIMINOVITCH
Citations
Apr 10, 2002·International Journal of Hematology·Taroh Kinoshita, Norimitsu Inoue
Mar 12, 2003·International Journal of Hematology·Norimitsu InoueTaroh Kinoshita
Sep 20, 2011·International Journal of Hematology·Kyoko TaniguchiHiroyasu Ogawa
Sep 10, 2003·Experimental Hematology·Shashikant Kulkarni, Monica Bessler
Feb 10, 2006·Leukemia·M OkamotoY Maruyama
May 1, 2004·Medicine·Jun-Ichi NishimuraWendell F Rosse
Feb 3, 2005·Blood·Rong HuRobert A Brodsky
Mar 15, 2006·International Journal of Hematology·Mitsuhiro OmineGérard Socié
Aug 7, 2007·International Journal of Hematology·Tatsuya Kawaguchi, Hideki Nakakuma
Jun 1, 2008·Biologics : Targets & Therapy·Antonio M Risitano, Bruno Rotoli
Mar 24, 2007·Experimental Hematology·Charles J Parker
Mar 30, 2007·Critical Reviews in Oncology/hematology·Martin SternCatherine Nissen-Druey
Aug 13, 2004·American Journal of Hematology·Carla BoschettiAlberto Zanella
Dec 5, 2003·Transfusion Medicine·J C W Marsh, M O Elebute
Feb 20, 2004·Hematology·Tsutomu Shichishima, Hideyoshi Noji
Feb 18, 2003·British Journal of Haematology·Phil J AncliffDavid C Linch
Feb 22, 2012·PloS One·Liesbeth LenaertsLieve Naesens
Mar 9, 2010·PloS One·Elizabeth SweeneyOlena Jacenko
May 19, 2017·Nature Reviews. Disease Primers·Anita HillRobert A Brodsky
Jul 6, 2018·British Journal of Haematology·Lucio Luzzatto, Antonio M Risitano
Jun 8, 2007·Leukemia·R TiuJ P Maciejewski
Mar 14, 2020·British Journal of Haematology·Lucio Luzzatto
Dec 20, 2002·Blood Cells, Molecules & Diseases·Jun-ichi NishimuraWendell F Rosse
Dec 17, 2008·Medicina clínica·Pilar M Hernández-CampoAlberto Orfao